Ironwood Pharmaceuticals is trading 5.4% higher at $4.30, with no clear catalyst identified for the move.
- This reverses the August 13, 2026 close of $4.08.
- No new company-specific announcement or credible report directly explaining the August 14, 2026 move was identified.
- The broader market is modestly lower; recent company news remains centered on August 6 second-quarter results and raised 2026 guidance.